ATLAS / Macro Radar / Reporting / SLN

Silence Therapeutics plc (SLN) reporting calendar

Silence Therapeutics plc files periodic reports with the SEC as SLN on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
30 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 48 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open SLN market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-210446
10-K31 Dec 20255 Mar 202664 days0001193125-26-092591
10-Q30 Sep 20256 Nov 202537 days0001193125-25-268116
10-Q30 Jun 20257 Aug 202538 days0000950170-25-104593
10-Q31 Mar 20258 May 202538 days0000950170-25-066439
10-K31 Dec 202427 Feb 202558 days0000950170-25-029129
20-F31 Dec 202313 Mar 202473 days0000950170-24-030519
20-F31 Dec 202215 Mar 202374 days0000950170-23-007992
20-F31 Dec 202117 Mar 202276 days0001564590-22-010774
20-F31 Dec 202030 Mar 202189 days0001564590-21-016738

Source: SEC EDGAR company submissions for CIK 0001479615. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.